SCHEMBL8024923

SCHEMBL8024923

CCCCCCCCOP(OCCC#N)N(C(C)C)C(C)C

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39
SPHK1 Q9NYA1 1/20 0.30
ZDHHC20 Q5W0Z9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27050968 1.00 TSHR (0.39) TSHRSPHK1ZDHHC20
SCHEMBL31465140 1.00 TSHR (0.39) TSHRSPHK1ZDHHC20
SCHEMBL14286742 1.00 TSHR (0.39) TSHRSPHK1ZDHHC20
SCHEMBL15935504 1.00 TSHR (0.39) TSHRSPHK1ZDHHC20
SCHEMBL7650398 1.00 TSHR (0.39) TSHRSPHK1ZDHHC20
SCHEMBL13169264 1.00 TSHR (0.39) TSHRSPHK1ZDHHC20
SCHEMBL7873800 1.00 TSHR (0.39) TSHRSPHK1ZDHHC20
SCHEMBL5308716 1.00 TSHR (0.39) TSHRSPHK1ZDHHC20
SCHEMBL17725159 1.00 TSHR (0.39) TSHRSPHK1ZDHHC20
SCHEMBL7875756 1.00 TSHR (0.39) TSHRSPHK1ZDHHC20

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727969-A2 METHODS FOR PROVIDING INTERCELLULAR COMMUNICATION Rethink64 Bionetworks PBC (US) 2026-04-22 EP disclosed
WO-2024259374-A2 METHODS FOR PROVIDING INTERCELLULAR COMMUNICATION RETHINK64 BIONETWORKS PBC (US) 2024-12-19 WO disclosed
US-6107479-A INTRODUCING A NONREMOVABLE LIPOPHILIC CAPPING GROUP TO AN UNREACTED REACTIVE GROUP OF OLIGOMER WHICH WAS NOT CHAIN EXTENDED IN PREVIOUS STEP, THEN SEPARATING CAPPED OLIGOMER FROM ELONGATED OLIGOMER ON A HYDROPHOBIC STATIONARY PHASE NOVARTIS AG (CH) 2000-08-22 US disclosed
WO-1998020018-A1 PROCESS FOR THE PREPARATION OF AN OLIGOMERIC COMPOUND NOVARTIS AG (CH) 1998-05-14 WO disclosed